AMARIN CORPORATION PLC - AMERICAN DEPOSITARY SHARE

Amarin Reports Second Quarter and Six Month 2021 Financial Results and Provides Business Update

05 8 2021 05:00:01 提供 Nasdaq GlobeNewswire

Amarin to Report Second Quarter and Six Month 2021 Financial Results and Host Conference Call on August 5, 2021

15 7 2021 05:35:00 提供 Nasdaq GlobeNewswire

Further Insights into Mechanism of Action of Icosapent Ethyl and Its Unique Form of Eicosapentaenoic Acid (EPA) Presented at the European Atherosclerosis Society (EAS) Congress 2021

02 6 2021 15:30:00 提供 Nasdaq GlobeNewswire

Amarin to Present at Two Investor Conferences in June 2021

18 5 2021 05:05:00 提供 Nasdaq GlobeNewswire

Amarin Highlights Multiple Scientific Findings for VASCEPA® (Icosapent Ethyl) and Its Unique Active Ingredient at the American College of Cardiology’s 70th Annual Scientific Session

17 5 2021 15:05:02 提供 Nasdaq GlobeNewswire

REDUCE-IT® Heart Failure Analyses by VASCEPA® (Icosapent Ethyl)-Driven Serum Eicosapentaenoic Acid (EPA) Levels Suggest Potential Benefit in New Heart Failure in Studied At-Risk Patients as Presented at the American College of Cardiology’s 70th Annual Scientific Session

15 5 2021 07:00:00 提供 Nasdaq GlobeNewswire

Clinical Data and Other Research Results Regarding VASCEPA® (Icosapent Ethyl) and Its Unique Active Ingredient to Be Presented at the American College of Cardiology’s 70th Annual Scientific Session

04 5 2021 06:00:01 提供 Nasdaq GlobeNewswire

Amarin Reports First Quarter 2021 Financial Results and Provides Business Update

29 4 2021 05:10:00 提供 Nasdaq GlobeNewswire

Amarin Announces Planned Retirement of Joseph T. Kennedy, EVP, General Counsel

29 4 2021 05:00:00 提供 Nasdaq GlobeNewswire

Amarin Receives Great Britain Marketing Authorization for VAZKEPA from the Medicines and Healthcare Products Regulatory Agency (MHRA) 1,2

22 4 2021 09:53:02 提供 Nasdaq GlobeNewswire